English
SpanishTrusted Resources: People & Places
Healthcare providers, researchers, and advocates
Stanford Healthcare – Spinal Muscular Atrophy
213 Quarry RoadPalo Alto, California, United States
Phone Web
Stanford Neuromuscular Program has extensive experience in diagnosing and treating spinal muscular atrophy (SMA). We are at the forefront of developing and validating new treatment approaches, such as Spinraza, the only treatment available for spinal muscular atrophy.
This disease-modifying drug halts the progression of spinal muscular atrophy and may help people regain some of the motor function they have lost. Our research team treated the first infant ever to receive Spinraza in 2013. After the FDA approved Spinraza in 2016, we treated the very first adult living with spinal muscular atrophy.
We offer specialized, comprehensive care for those living with spinal muscular atrophy at our multidisciplinary Neuromuscular Clinic Program.
BookmarkRelated Content
-
Seattle Children’s Hospital – Spinal Muscular AtrophySeattle Children’s Neuromuscular Progr...
-
The Pediatric SMA Clinic – Columbia UniversityThe Pediatric SMA Clinic is committed to...
-
Quality of Life Assessment in Adult Spinal Muscular Atrophy Patients Treated With NusinersenObjective: To retrospectively evaluate q...
-
Assessing Cognitive Function in Neuromuscular Diseases: A Pilot Study in a Sample of Children and AdolescentsCentral nervous system (CNS) involvement...
-
Targeted NGS Seen as Best When Screening for SMA and Its CarriersTargeted next generation sequencing (NGS...
-
Detection of Spinal Muscular Atrophy Patients Using Dried Saliva SpotsSpinal muscular atrophy (SMA) is a lower...
-
Your Guide to Spinal Muscular Atrophyhttps://simedhealth.com/sites/default/fi...
